Sunshine Holdings' 3Q highlights strategic expansions into consumer and healthcare

Diversified conglomerate Sunshine Holdings reported resilient growth in top and bottom-line performances during the first nine months of the current financial year (9MFY21), with strong contributions kicking in from the healthcare, agribusiness, and consumer sectors.

During this period, the group posted a consolidated revenue of Rs.17.4 billion, up by 10 per cent year-on-year (YoY); group profit after tax (PAT) saw an increase of 11 per cent YoY compared to last year, amounting to Rs.1.9 billion.

The group announced the merger of its healthcare business consisting of Sunshine Healthcare Lanka and Healthguard Pharmacy with the healthcare arm of Akbar Brothers, which consists of Akbar Pharmaceuticals, Lina Manufacturing, and Lina Spiro.

The strategic merger, which was finalized last month, created Sri Lanka’s first fully-integrated healthcare company, starting from manufacturing up to retailing of healthcare products, including last-mile distribution across the country for all healthcare products.

Sunshine Healthcare now operates in all five segments of the healthcare supply chain, namely research and development (R&D), manufacturing, importation, distribution and retail.